Get started
Author

Jule Taubmann

Observed names: Jule Bachl, Taubmann, Jule
ORCID: 0009-0002-6068-3897
Observed ORCID: 0009-0002-6068-3897
OpenAlex ID: A5052157434
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
2024 · Fabian Müller, Jule Taubmann, et al. · New England Journal of Medicine · 1,231
Advancements and challenges in CAR T cell therapy in autoimmune diseases
2024 · Georg Schett, Fabian Müller, et al. · Nature Reviews Rheumatology · 288
CD19-targeted CAR T cells in refractory antisynthetase syndrome
2023 · Fabian Müller, Sebastian Boeltz, et al. · The Lancet · 280
PDF
Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
2023 · Christina Bergmann, Fabian Müller, et al. · Annals of the Rheumatic Diseases · 236
PDF
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series
2024 · Janina Auth, Fabian Müller, et al. · The Lancet Rheumatology · 150
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study
2025 · Melanie Hagen, Fabian Müller, et al. · The Lancet Rheumatology · 115
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
2026 · Fabian Müller, Melanie Hagen, et al. · Nature Medicine · 112
PDF
Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies
2023 · Jule Taubmann, Johannes Knitza, et al. · Rheumatology · 97
PDF
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells
2025 · Fabian Müller, Andreas Wirsching, et al. · Nature Medicine · 95
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
2020 · Jule Taubmann, Brenda Krishnacoumar, et al. · Scientific Reports · 89
PDF
CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus
2023 · Jule Taubmann, Fabian Müller, et al. · Arthritis & Rheumatology · 81
Effects of different B-cell-depleting strategies on the lymphatic tissue
2025 · Carlo Tur, Markus Eckstein, et al. · Annals of the Rheumatic Diseases · 75
PDF
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
2025 · Fabian Müller, Nora Rebecca Schwingen, et al. · Blood · 47
An AI-Powered Clinical Decision Support System to Predict Flares in Rheumatoid Arthritis: A Pilot Study
2023 · Hannah Labinsky, Dubravka Ukalovic, et al. · Diagnostics · 39
PDF
PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass
2020 · Dorothea I. H. Müller, Cornelia Stoll, et al. · Scientific Reports · 25
PDF
Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine Production
2024 · Janin Dingfelder, Michael Aigner, et al. · Transplantation and Cellular Therapy · 21
CD19-Targeted CAR-T Cells in Refractory Systemic Autoimmune Diseases: A Monocentric Experience from the First Fifteen Patients
2023 · Fabian Mueller, Jule Taubmann, et al. · Blood · 19
Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study
2022 · David Simon, Koray Tascilar, et al. · The Lancet Rheumatology · 19
PDF
Real-World-Evidence of Digital Health Applications (DiGAs) in Rheumatology: Insights from the DiGAReal Registry
2025 · Alexander Albrecht, Jule Taubmann, et al. · Rheumatology and Therapy · 17
PDF
Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus–associated refractory cerebral vasculitis induces immune tolerance
2022 · Melek Yalcin Mutlu, Jochen Wacker, et al. · Rheumatology · 15
Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients
2025 · Janin Dingfelder, Jule Taubmann, et al. · International Journal of Molecular Sciences · 11
PDF
Langzeitverlauf von Effizienz und Sicherheit der CD19-CAR T-Zell-Therapie beim systemischen Lupus erythematodes
2025 · Jule Taubmann, Sebastian Böltz, et al. · Zeitschrift für Rheumatologie · 10
PDF
CAR-T Cell Therapy in Patients with Refractory Systemic Autoimmune Diseases Exhibits Less Inflammation, Toxicities and Different Cellular Dynamics Compared to Patients with B Cell Lymphoma
2023 · Fabian Mueller, Nora Rebecca Schwingen, et al. · Blood · 7
Effects of CD19 CAR T Cell Therapy on Quality of Life and Direct Healthcare Costs in Systemic Lupus Erythematosus: A Preliminary Analysis
2025 · Jule Taubmann, Melanie Hagen, et al. · The Journal of Rheumatology · 6
Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell–depleting antibodies: reply
2023 · Jule Taubmann, Johannes Knitza, et al. · Rheumatology · 6
Works count: 39
Citation count: 3,103
H-index: 18
I10-index: 22
Year
Topic
Type